Search Results 1 – 20 of 89
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Periconception, Antepartum, and Postpartum Periods
Special Populations
Appendix C: CDC Pediatric HIV CD4 Cell Count/Percentage and HIV-Related Diseases Categorization
Mpox
Appendix B: Drug Characteristics Tables
Recommendations for Use of Antiretroviral Drugs During Pregnancy
Infant Feeding for Individuals With HIV in the United States
Statin Therapy in People With HIV
Talaromycosis (formerly Penicilliosis)
Appendix B: Panel Roster and Financial Disclosures
Prepregnancy Counseling and Care for Persons of Childbearing Age With HIV
Appendix B: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Tables
Guidelines Panel Members
Cytomegalovirus Disease
Limitations to Treatment Safety and Efficacy
Considerations for Antiretroviral Use in People With Coinfections
Appendix A: Key to Acronyms
Antepartum Care
Appendix A: Pediatric Antiretroviral Drug Information